PHARMOCANN GLOBAL Current Financial Leverage

PHARMOCANN GLOBAL's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. PHARMOCANN GLOBAL's financial risk is the risk to PHARMOCANN GLOBAL stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Check out Your Equity Center.

PHARMOCANN Bonds 

 
Refresh

PHARMOCANN GLOBAL Financial Leverage Rating

PHARMOCANN GLOBAL bond ratings play a critical role in determining how much PHARMOCANN GLOBAL have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for PHARMOCANN GLOBAL's borrowing costs.
Overall Bond Rating
Not Rated
Average S&P Rating
N/A

PHARMOCANN GLOBAL Debt to Cash Allocation

As PHARMOCANN GLOBAL follows its natural business cycle, the capital allocation decisions will not magically go away. PHARMOCANN GLOBAL's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors. Many companies eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has accumulated 2.94 M in total debt with debt to equity ratio (D/E) of 0.08, which may suggest the company is not taking enough advantage from borrowing. PHARMOCANN GLOBAL has a current ratio of 6.3, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

PHARMOCANN GLOBAL Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the PHARMOCANN GLOBAL's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of PHARMOCANN GLOBAL, which in turn will lower the firm's financial flexibility. Like all other financial ratios, a a PHARMOCANN GLOBAL debt ratio should be compared their industry average or other competing firms.

Be your own money manager

Our tools can tell you how much better you can do entering a position in PHARMOCANN GLOBAL without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamental Analysis Now

   

Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

Currently Active Assets on Macroaxis

Check out Your Equity Center. Note that the PHARMOCANN GLOBAL information on this page should be used as a complementary analysis to other PHARMOCANN GLOBAL's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Tools for PHARMOCANN Stock

When running PHARMOCANN GLOBAL price analysis, check to measure PHARMOCANN GLOBAL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PHARMOCANN GLOBAL is operating at the current time. Most of PHARMOCANN GLOBAL's value examination focuses on studying past and present price action to predict the probability of PHARMOCANN GLOBAL's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move PHARMOCANN GLOBAL's price. Additionally, you may evaluate how the addition of PHARMOCANN GLOBAL to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go